Home > News > Biotech firms courting investors
November 5th, 2007
Biotech firms courting investors
Abstract:
Like another Cambridge biotech company, Alkermes Inc., Bind is trying to find better ways to deliver drugs - rather than trying to invent new drugs. Bind is focused on using nanotechnology to concentrate drugs in the areas affected by a disease, where they can be most effective. The company was cofounded by MIT professor Robert Langer and Harvard Medical School assistant professor Omid Farokhzad.
Source:
boston.com
Bookmark:
VC/Funding/Angel financing/Loans/Leases
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Nanostart-holding MagForce Receives Further Patent Related to NanoTherm Therapy May 7th, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
Moth-Inspired Nanostructures Take the Color Out of Thin Films May 17th, 2013
Add boron for better batteries: Rice University theorists say graphene-boron mix shows promise for lithium-ion batteries May 17th, 2013
DNA-Guided Assembly Yields Novel Ribbon-Like Nanostructures: Approach could be useful in fabricating new kinds of materials with engineered properties May 16th, 2013
Advancements and developments of solid-state nanopores sensors May 16th, 2013
Events/Classes
Interactive Printed Products – New Applications Enabled by Organic and Printed Electronics May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
INSCX™ exchange to present a nanotechnology-based Emission Reduction Programme, Ankara, Turkey, June 2013 May 14th, 2013
VDMA: New “Photonics Industry Report 2013” presented May 14th, 2013